Effects of Virtual Reality Exercise on Promoting Physical Activity and Health Among College Students

March 27, 2025 updated by: Zan Gao, The University of Tennessee, Knoxville

Effects of Virtual Reality Exercise on Promoting Physical Activity and Health Among College Students: A 4-week Randomized Controlled Trial

The purpose of this research is to examine the effectiveness of a 4-week immersive-virtual reality (VR) exercise bike intervention on college students' physiological outcomes (physical activity levels, cardiovascular fitness, and body composition) and psychological outcomes (situational motivation, situational interest, mood states, and depressive symptoms).

Study Overview

Study Type

Interventional

Enrollment (Actual)

36

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Minnesota
      • Minneapolis, Minnesota, United States, 55455
        • University of Minnesota, Twin Cities

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • College students age from 18 to 35 years old who are currently enrolled in the university
  • College students without diagnosed physical and/or mental disabilities
  • Must be willing to provide informed consent and compete the PA Readiness Questionnaire (PAR-Q)
  • Must be willing to be randomized into an intervention or control group
  • no self-reported motion sickness symptoms during immersive VR-based exercise

Exclusion Criteria:

  • Students under the age of 18 or over the age of 35 years old or not currently enrolled in the university
  • Having self-reported physical and/or mental disabilities
  • Contradictions to PA participation as determined by PAR-Q responses
  • having motion sickness reaction when exercising under VR-based condition.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Exercise on immersive VR-based bike
Participants were asked to exercise on an immersive VR-based exercise bike for one hour per session, two times per week, for 4 weeks
For the intervention group, participations exercised on an immersive VR-based exercise bike for one hour, twice per week, for 4 weeks. Participants in the control group were asked to maintain their usual routine after the baseline test for 4 weeks. Participants were scheduled separately coming to lab for the post-test after 4 weeks and all participants received the identical assessments in aforementioned physiological and psychological outcomes.
Active Comparator: Usual routine
Participants in the control group were asked to maintain their usual routine after the baseline test for 4 weeks. Participants were scheduled separately coming to lab for the post-test after 4 weeks and all participants received the identical assessments in aforementioned physiological and psychological outcomes.
Participants were asked to maintain their usual activities, without engaging in any other physical activity intervention during the 4-week study period.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Exercise Motivation
Time Frame: Baseline, and 4 weeks
Participants' motivation were assessed by the Behavioral Regulation in Exercise Questionnire-2 (BREQ-2). The BREQ-2 has 19 items assessing the continuum of behavioral regulation in exercise, which included amotivation, external regulation, introjected regulation, identified regulation, and intrinsic regulation.
Baseline, and 4 weeks
Mood States
Time Frame: Baseline, and 4 weeks
Participants' mood states were measured by the Brunel Mood Scale (BRUMS). The BRUMS assesses mood across six subscales (anger, confusion, depression, fatigue, tension, and vigor) using a 24-item questionnaire with responses ranging from 0 (not at all) to 4 (extremely).
Baseline, and 4 weeks
Depressive Symptoms
Time Frame: Baseline, and 4 weeks
The Beck Depression Inventory (BDI) was used to assess participant's depressive symptoms. This is a 21-item, self-report rating inventory that measures characteristic attitudes and symptoms of depression. The total score was calculated to the evaluate the severity of depressive symptoms.
Baseline, and 4 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Cardiovascular fitness levels
Time Frame: Baseline, and 4 weeks
Investigators asked participants to step on and off of a 12-inch plyometric box for 3 minutes to the "beep" of a metronome set to 96 beats-per-minute, with each beep corresponding with one leg movement. Immediately following the completion of the test, the principal investigator measured participants' heart rate for 60 seconds via palpation of the radial artery on the underbelly of the left wrist.
Baseline, and 4 weeks
Physical activity levels
Time Frame: Baseline, and 4 weeks

Physical activity levels were assessed via International Physical Activity Questionnaire (IPAQ). The IPAQ assesses three specific types of activity: walking, moderate-intensity activities, and vigorous-intensity activities. It asks participants to recall the time (in minutes) spent on each of these activities in the past 7 days.

Each participant were assigned an accelerometer to wear during each 60-minute exercise session. Prior to the start of the intervention, participants were asked to wear an accelerometer for one week for measuring their physical activity levels. In addition, the investigators asked participants to wear the accelerometer for another week at the completion of 4-week intervention.

Baseline, and 4 weeks
Body Mass Index
Time Frame: Baseline, and 4 weeks
Participant height (cm) and weight (kg) were measured using a stadiometer and a Tanita BC-558 IRONMAN Segmental Body Composition Monitor, respectively, in theUniversity of Minnesota's Physical Activity Epidemiology Laboratory. Both height and weight were used to calculate BMI in kg/m². BMI was classified according to the following indicators: Underweight: BMI < 18.5; Normal weight: BMI 18.5-24.9; Overweight: BMI 25-29.9; Obesity: BMI ≥ 30.
Baseline, and 4 weeks
Percent of body fat
Time Frame: Baseline, and 4 weeks
Percent of body fat (%BF) were measured by Tanita BC-558 IRONMAN Segmental Body Composition Monitor.
Baseline, and 4 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 28, 2020

Primary Completion (Actual)

November 1, 2020

Study Completion (Actual)

July 1, 2021

Study Registration Dates

First Submitted

March 3, 2025

First Submitted That Met QC Criteria

March 27, 2025

First Posted (Actual)

March 30, 2025

Study Record Updates

Last Update Posted (Actual)

March 30, 2025

Last Update Submitted That Met QC Criteria

March 27, 2025

Last Verified

March 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

De-identified participant data, including primary and secondary outcomes, and relevant demographic will be made publicly available. Data will be accessible through a public data repository. Researchers interested in accessing these datasets can request or directly download them via https://www.openicpsr.org/openicpsr/project/223741/version/V1/view

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Body Composition

Clinical Trials on VR-based exercise bike

Subscribe